Advanced Search

ICD-10-PCS code List for Monoclonal Antibody

ICD-10-PCS code List for Monoclonal Antibody is medical classification list by Centers for Medicare and Medicaid Services (CMS).

PCS Tables

PCS CODE

Description

Introduction of Adhesion Barrier into Peritoneal Cavity, Open Approach

Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach

Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach

Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach

Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach

Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach

Introduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach

Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Approach

Introduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach

Introduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach

Introduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach

Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach

Introduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach

Introduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach

Introduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach

Introduction of Other Gas into Peritoneal Cavity, Percutaneous Approach

Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach

Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Endoscopic Approach

Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Endoscopic Approach

Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening

Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening

Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening

Introduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening